Nucleostemin and TWIST as predictive markers for recurrence after neoadjuvant chemotherapy for esophageal carcinoma

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Cancer Science

• Publication date

  2012-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1349-7006.2011.02142.xPMID 22050045
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Maintenance of tumor initiating cells of defined genetic composition by nucleostemin

  2011cited by this paper
• PSF1, a DNA replication factor expressed widely in stem and progenitor cells, drives tumorigenic and metastatic properties.

  2010cited by this paper
• Twist, an independent prognostic marker for predicting distant metastasis and survival rates of esophageal squamous cell carcinoma patients

  2009cited by this paper
• Identification of tumor-initiating cells in a highly aggressive brain tumor using promoter activity of nucleostemin

  2009cited by this paper
• TNM Classification of Malignant Tumours, 7th Edition

  2009cited by this paper
• The epithelial-mesenchymal transition generates cells with properties of stem cells.

  2008cited by this paper
• Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.

  2008cited by this paper
• Advances in esophageal cancer surgery in Japan: an analysis of 1000 consecutive patients treated at a single institute.

  2008cited by this paper
• Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer.

  2007cited by this paper
• Cancer stem cells and tumor metastasis: first steps into uncharted territory.

  2007cited by this paper
• Chemotherapy and cancer stem cells.

  2007cited by this paper
• Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4.

  2007cited by this paper
• Upregulation of Twist in oesophageal squamous cell carcinoma is associated with neoplastic transformation and distant metastasis

  2006cited by this paper
• Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

  2006cited by this paper
• Guide lines for the clinical and pathologic studies for carcinoma of the esophagus

  2006cited by this paper
• Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.

  2004cited by this paper
• Prospective identification of tumorigenic breast cancer cells

  2003cited by this paper
• Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection

  2003cited by this paper
• A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells.

  2002cited by this paper
• Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973–1995

  2002cited by this paper
• Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial.

  2002cited by this paper

• IMUMUNOHISTOCHEMICAL ANALYSIS OF CD133 AND NUCLEOSTEMIN IN SQUAMOUS CELL CARCINOMA AND ADENOCARCINOMA

  2024cites this paper
• Prognostic and clinicopathological value of Twist expression in esophageal cancer: A meta-analysis

  2022cites this paper
• G protein nucleolar 3 promotes Non-Hodgkin lymphoma progression by activating the Wnt/β-catenin signaling pathway.

  2021cites this paper
• Angiogenesis-related non-coding RNAs and gastrointestinal cancer

  2021cites this paper
• Prognostic value of stem cell markers in esophageal and esophagogastric junction cancer: a meta-analysis

  2020influential citation
• Clinical implications of cancer stem cells in digestive cancers: acquisition of stemness and prognostic impact

  2020cites this paper
• Clinical Significance of TWIST-Positive Circulating Tumor Cells in Patients with Esophageal Squamous Cell Carcinoma

  2020cites this paper
• Prognostic and Clinical Value of CD44 and CD133 in Esophageal Cancer: A Systematic Review and Meta-analysis.

  2020cites this paper
• Nucleostemin expression in breast cancer is a marker of more aggressive phenotype and unfavorable patients’ outcome

  2019cites this paper
• The oncogenic role of GNL3 in the progression and metastasis of osteosarcoma

  2019cites this paper
• Expression of Cancer Stem Cell Biomarkers in Human Head and Neck Carcinomas: a Systematic Review

  2018cites this paper
• Antrodia cinnamomea mycelial fermentation broth inhibits the epithelial-mesenchymal transition of human esophageal adenocarcinoma cancer cells.

  2018cites this paper
• MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF

  2017cites this paper
• Esophageal adenocarcinoma microenvironment: Peritumoral adipose tissue effects associated with chemoresistance

  2017cites this paper
• Title MicroRNA-377 suppresses initiation and progression ofesophageal cancer by inhibiting CD 133 and VEGF

  2017cites this paper
• TWIST1 and BMI1 in Cancer Metastasis and Chemoresistance

  2016cites this paper
• Guanine nucleotide binding protein-like 3 is a potential prognosis indicator of gastric cancer.

  2015cites this paper
• Clinical significance of nucleostemin and proliferating cell nuclear antigen protein expression in non-small cell lung cancer.

  2015cites this paper
• Knockdown of nucleostemin can inhibit the proliferation of esophageal carcinoma cells in vitro through upregulating p21.

  2014cites this paper
• Prognostic role of Twist or Snail in various carcinomas: a systematic review and meta‐analysis

  2014cites this paper
• Nucleostemin stabilizes ARF by inhibiting the ubiquitin ligase ULF

  2014cites this paper
• Nucleostemin expression in invasive breast cancer

  2014cites this paper
• Overexpression of nucleostemin contributes to an advanced malignant phenotype and a poor prognosis in oral squamous cell carcinoma

  2014cites this paper
• Vaccine-mediated immunotherapy directed against a transcription factor driving the metastatic process.

  2014cites this paper
• Significance of CD133 expression in esophageal squamous cell carcinoma

  2013cites this paper